South Korea To Become One Of 1st To Launch Full-Scale Production Of Sputnik-V Abroad
Faizan Hashmi Published April 16, 2021 | 01:40 PM
SEOUL (UrduPoint News / Sputnik - 16th April, 2021) South Korea will become one of the first countries to launch the full-scale production of Russia's coronavirus vaccine Sputnik V abroad, as the process of technology transfer to pharmaceutical companies in the Asian country is nearing completion.
South Korea is at the forefront among foreign vaccine production partners of the Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund that is behind Sputnik V exports, as two consortiums � one led by biotech companies GL Rapha and ISU ABXIS and another by pharmaceutical company Huons Global � already inked deals with RDIF on technology transfer and production of the vaccine.
"I cannot say for sure what the situation is at the factories producing Sputnik V in India, China and other countries, but, as far as I know, South Korea is at the forefront of RDIF's foreign contract manufacturing partners," GL Rapha's representative, Kim Gi Young, told Sputnik.
RDIF reached the agreement on technology transfer and the vaccine's production with GL Rapha and ISU ABXIS on Thursday, marking the first case of the consortium officially signing a contract with RDIF that included the actual technology transfer.
According to Kim, GL Rapha has already sent an inspection batch of the vaccine to Russia to complete the validation procedure and expects to be able to start full-scale production in the near future.
The second consortium, including also Prestige BioPharma, Humedix and Boran Pharma companies, that will complement the one organized by GL Rapha, inked the deal earlier on Friday, with Huons Global planning to launch the pilot production in August, the South Korean company told Sputnik.
"So far, we cannot disclose detailed schedules for receiving equipment and setting up production, as well as volume obligations, but later we can inform about them. The volumes of supplies, amounts and other details are currently the subject of nondisclosure under the contract. However, we can confirm that we have agreed on a technology transfer," the company added.
All vaccines produced by both groups in South Korea will be exported abroad, while the Asian country itself does not use Sputnik V.
Related Topics
Recent Stories
HEC reviews curricula for environmental sciences degree programme
ICC Asia looking forward to an action-packed Asia Cricket Week
Yuvraj Singh named ICC Men’s T20 World Cup 2024 Ambassador
Greece hands Olympic flame to 2024 Paris Games hosts
Two Kyiv hospitals evacuating over feared Russian strikes
World must act on neurotech revolution, say experts
Charles & Catherine's cancer diagnoses
Champions Alcaraz and Sabalenka through in Madrid Open
King Charles to resume some public duties during cancer treatment: palace
US defense chief announces $6 bn in security aid for Ukraine
Heavy rains cause damage to Spezand-Taftan railway track
Woman stabbed in Israel, attacker killed: police
More Stories From World
-
Tennis: ATP/WTA Madrid Open results - collated
22 minutes ago -
PGA Zurich Classic of New Orleans scores
22 minutes ago -
Sudanese filmmakers shine light on war's 'silent problems'
22 minutes ago -
NFL will allow players to wear Guardian Cap helmets in games
7 hours ago -
Football: German Bundesliga table
7 hours ago -
Football: Italian Serie A result
7 hours ago
-
Football: German Bundesliga results
7 hours ago -
US troops to leave Chad in second African state withdrawal
7 hours ago -
Plastics pollution may be solved without production cap: Canada minister
7 hours ago -
Biden stalls on menthol cigarette ban fearing Black vote backlash
7 hours ago -
Champions Alcaraz and Sabalenka through in Madrid Open
7 hours ago -
6,000 French police to welcome Olympic torch amid bonus boost
8 hours ago